These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 32365861)

  • 1. Automated Large-Scale Production of Paclitaxel Loaded Mesenchymal Stromal Cells for Cell Therapy Applications.
    Lisini D; Nava S; Frigerio S; Pogliani S; Maronati G; Marcianti A; Coccè V; Bondiolotti G; Cavicchini L; Paino F; Petrella F; Alessandri G; Parati EA; Pessina A
    Pharmaceutics; 2020 Apr; 12(5):. PubMed ID: 32365861
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cell-mediated drug delivery by gingival interdental papilla mesenchymal stromal cells (GinPa-MSCs) loaded with paclitaxel.
    Brini AT; Coccè V; Ferreira LM; Giannasi C; Cossellu G; Giannì AB; Angiero F; Bonomi A; Pascucci L; Falchetti ML; Ciusani E; Bondiolotti G; Sisto F; Alessandri G; Pessina A; Farronato G
    Expert Opin Drug Deliv; 2016 Jun; 13(6):789-98. PubMed ID: 26986001
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mesenchymal stromal cells loaded with paclitaxel induce cytotoxic damage in glioblastoma brain xenografts.
    Pacioni S; D'Alessandris QG; Giannetti S; Morgante L; De Pascalis I; Coccè V; Bonomi A; Pascucci L; Alessandri G; Pessina A; Falchetti ML; Pallini R
    Stem Cell Res Ther; 2015 Oct; 6():194. PubMed ID: 26445228
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adipose tissue-derived stromal cells primed in vitro with paclitaxel acquire anti-tumor activity.
    Bonomi A; Coccè V; Cavicchini L; Sisto F; Dossena M; Balzarini P; Portolani N; Ciusani E; Parati E; Alessandri G; Pessina A
    Int J Immunopathol Pharmacol; 2013; 26(1 Suppl):33-41. PubMed ID: 24046947
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fluorescent Immortalized Human Adipose Derived Stromal Cells (hASCs-TS/GFP+) for Studying Cell Drug Delivery Mediated by Microvesicles.
    Cocce V; Balducci L; Falchetti ML; Pascucci L; Ciusani E; Brini AT; Sisto F; Piovani G; Alessandri G; Parati E; Cabeza L; Pessina A
    Anticancer Agents Med Chem; 2017 Nov; 17(11):1578-1585. PubMed ID: 28356007
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Paclitaxel Priming of TRAIL Expressing Mesenchymal Stromal Cells (MSCs-TRAIL) Increases Antitumor Efficacy of Their Secretome.
    Coccè V; Bonomi A; Cavicchini L; Sisto F; Giannì A; Farronato G; Alessandri G; Petrella F; Sordi V; Parati E; Bondiolotti G; Paino F; Pessina A
    Curr Cancer Drug Targets; 2020 Nov; ():. PubMed ID: 33200709
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synergistic Chemo-Photothermal Therapy of Breast Cancer by Mesenchymal Stem Cell-Encapsulated Yolk-Shell GNR@HPMO-PTX Nanospheres.
    Wu J; Liu Y; Tang Y; Wang S; Wang C; Li Y; Su X; Tian J; Tian Y; Pan J; Su Y; Zhu H; Teng Z; Lu G
    ACS Appl Mater Interfaces; 2016 Jul; 8(28):17927-35. PubMed ID: 27356586
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adipose tissue-derived mesenchymal stromal cells for clinical application: An efficient isolation approach.
    Lisini D; Nava S; Pogliani S; Avanzini MA; Lenta E; Bedini G; Mantelli M; Pecciarini L; Croce S; Boncoraglio G; Maccario R; Parati EA; Frigerio S
    Curr Res Transl Med; 2019 Feb; 67(1):20-27. PubMed ID: 30104160
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Paclitaxel is incorporated by mesenchymal stromal cells and released in exosomes that inhibit in vitro tumor growth: a new approach for drug delivery.
    Pascucci L; Coccè V; Bonomi A; Ami D; Ceccarelli P; Ciusani E; Viganò L; Locatelli A; Sisto F; Doglia SM; Parati E; Bernardo ME; Muraca M; Alessandri G; Bondiolotti G; Pessina A
    J Control Release; 2014 Oct; 192():262-70. PubMed ID: 25084218
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Paclitaxel-releasing mesenchymal stromal cells inhibit the growth of multiple myeloma cells in a dynamic 3D culture system.
    Bonomi A; Steimberg N; Benetti A; Berenzi A; Alessandri G; Pascucci L; Boniotti J; Coccè V; Sordi V; Pessina A; Mazzoleni G
    Hematol Oncol; 2017 Dec; 35(4):693-702. PubMed ID: 27283119
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human amniotic mesenchymal stromal cells (hAMSCs) as potential vehicles for drug delivery in cancer therapy: an in vitro study.
    Bonomi A; Silini A; Vertua E; Signoroni PB; Coccè V; Cavicchini L; Sisto F; Alessandri G; Pessina A; Parolini O
    Stem Cell Res Ther; 2015 Aug; 6(1):155. PubMed ID: 26315881
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human mesenchymal stromal cells inhibit tumor growth in orthotopic glioblastoma xenografts.
    Pacioni S; D'Alessandris QG; Giannetti S; Morgante L; Coccè V; Bonomi A; Buccarelli M; Pascucci L; Alessandri G; Pessina A; Ricci-Vitiani L; Falchetti ML; Pallini R
    Stem Cell Res Ther; 2017 Mar; 8(1):53. PubMed ID: 28279193
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Drug Loaded Gingival Mesenchymal Stromal Cells (GinPa-MSCs) Inhibit In Vitro Proliferation of Oral Squamous Cell Carcinoma.
    Coccè V; Farronato D; Brini AT; Masia C; Giannì AB; Piovani G; Sisto F; Alessandri G; Angiero F; Pessina A
    Sci Rep; 2017 Aug; 7(1):9376. PubMed ID: 28839168
    [TBL] [Abstract][Full Text] [Related]  

  • 14. GMP-Compliant Production of Autologous Adipose-Derived Stromal Cells in the NANT 001 Closed Automated Bioreactor.
    Fitzgerald JC; Duffy N; Cattaruzzi G; Vitrani F; Paulitti A; Mazzarol F; Mauro P; Sfiligoj A; Curcio F; Jones DM; McInerney V; Krawczyk J; Kelly J; Finnerty A; McDonagh K; McCabe U; Duggan M; Connolly L; Shaw G; Murphy M; Barry F
    Front Bioeng Biotechnol; 2022; 10():834267. PubMed ID: 35356775
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Translation of a standardized manufacturing protocol for mesenchymal stromal cells: A systematic comparison of validation and manufacturing data.
    Rojewski MT; Lotfi R; Gjerde C; Mustafa K; Veronesi E; Ahmed AB; Wiesneth M; Körper S; Sensebé L; Layrolle P; Hellem S; Schrezenmeier H
    Cytotherapy; 2019 Apr; 21(4):468-482. PubMed ID: 30926359
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mesenchymal stromal cells loaded with Paclitaxel (PacliMES) a potential new therapeutic approach on mesothelioma.
    Coccè V; Bonelli M; La Monica S; Alfieri R; Doneda L; Martegani E; Alessandri G; Lagrasta CA; Giannì A; Sordi V; Petrella F; Roncoroni L; Paino F; Pessina A
    Biochem Pharmacol; 2023 Aug; 214():115678. PubMed ID: 37399948
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inactivated Platelet Lysate Supports the Proliferation and Immunomodulant Characteristics of Mesenchymal Stromal Cells in GMP Culture Conditions.
    Mareschi K; Castiglia S; Adamini A; Rustichelli D; Marini E; Banche Niclot AGS; Bergallo M; Labanca L; Ferrero I; Fagioli F
    Biomedicines; 2020 Jul; 8(7):. PubMed ID: 32708843
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mesenchymal stromal cells uptake and release paclitaxel without reducing its anticancer activity.
    Mariotti M; Colognato R; Rimoldi M; Rizzetto M; Sisto F; Cocce V; Bonomi A; Parati E; Alessandri G; Bagnati R; Pessina A
    Anticancer Agents Med Chem; 2015; 15(3):400-5. PubMed ID: 24942547
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human skin-derived fibroblasts acquire in vitro anti-tumor potential after priming with Paclitaxel.
    Pessina A; Coccè V; Bonomi A; Cavicchini L; Sisto F; Ferrari M; Ciusani E; Navone S; Marfia G; Parati E; Alessandri G
    Anticancer Agents Med Chem; 2013 Mar; 13(3):523-30. PubMed ID: 22931415
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A short-term plastic adherence incubation of the stromal vascular fraction leads to a predictable GMP-compliant cell-product.
    Born S; Dörfel MJ; Hartjen P; Haschemi Yekani SA; Luecke J; Meutsch JK; Westphal JK; Birkelbach M; Köhnke R; Smeets R; Krueger M
    Bioimpacts; 2019; 9(3):161-172. PubMed ID: 31508331
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.